大成生化科技(00809.HK)拟8月29日举行董事会会议批准中期业绩

Group 1 - The company, Dachen Biotech (00809.HK), announced that its board meeting will be held on August 29, 2025 [1] - The purpose of the meeting is to review and approve the unaudited interim results for the six months ending June 30, 2025, for the company and its subsidiaries [1] - The board will also consider the distribution of an interim dividend, if any [1]